MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Theravance Biopharma, Inc.

TBPH

#4646
Theravance Biopharma, Inc. - Ordinary Shares
0.1 6 USD
-99.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
0.16
0.16
Year Range
0.16
21.03
Daily Change
-99.01%
Monthly Change
-99.03%
6 month change
-99.20%
Year Change
-98.88%
Previous Close
16.2 1
Open
0.1 6
Low
0.1 6
High
0.1 6
Volume
94
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. TBPH
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 8.28 M
  • Employee 90
  • Founded 2013
  • CEO N/A
  • Website www.theravance.com
  • Headquarter California, United States
  • FIGI N/A
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
9.08
Price to sales ratio
8.97

News

Zacks Zacks
TBPH
2026.05.13
Are Options Traders Betting on a Big Move in Theravance Biopharma Stock?
Zacks Zacks
AMRN TBPH VTRS INDV
2026.05.08
TBPH Q1 Earnings Beat Amid Strategic Restructuring & Pipeline Hurdle
Zacks Zacks
TBPH
2026.05.07
Here's Why Theravance Biopharma (TBPH) is a Strong Momentum Stock
Zacks Zacks
XNCR TBPH
2026.05.06
Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates
Zacks Zacks
AGEN AMRN CORT TBPH
2026.05.01
CORT Q1 Earnings Match Estimates, Revenues Miss, 2026 Outlook Raised
Seeking Alpha Seeking Alpha
TBPH
2026.04.21
Theravance Biopharma: A Special Situation With A 50-100% Likely Upside (TBPH)
Zacks Zacks
CPRX TBPH VTRS INDV
2026.04.16
Theravance Stock Declines Around 17% in Three Months: Here's Why
Zacks Zacks
TBPH
2026.04.15
Here's Why Theravance Biopharma (TBPH) is a Strong Momentum Stock
Zacks Zacks
GSK CPRX TBPH VTRS
2026.03.20
Theravance's Q4 Earnings and Revenues Miss Estimates
Zacks Zacks
TBPH VVOS
2026.03.19
Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates
Zacks Zacks
ASRT TBPH
2026.03.16
Assertio (ASRT) Reports Q4 Loss, Beats Revenue Estimates
Zacks Zacks
TBPH
2026.03.09
Down 33.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Theravance Bio (TBPH)

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd